HR and breast cancer: Based on molecular and histological evidence, BC is categorized into three groups: BC expressing hormone receptor (HR), which refers to the estrogen receptor (ER) and progesterone receptor (PR), BC expressing human epidermal receptor 2 (HER2) and triple negative BC (ER-, PR- and HER2-) [9].